|
Index of reports
> Cases with Off Label Use ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Magnevist (Gadopentetate) where reactions include off label use. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Magnevist side effects in male
Reported by a consumer/non-health professional from United States on 2012-01-02
Patient: male, weighing 73.9 kg (162.6 pounds)
Reactions: Incorrect Route of Drug Administration, Wrong Technique in Drug Usage Process, Pain in Extremity, Nausea, Septic Arthritis Staphylococcal, Motor Dysfunction, Pain, Myalgia, Off Label Use, Fatigue
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Optiray 160
Dosage: 5-10 ml
Indication: X-RAY
Start date: 2009-04-29
End date: 2009-04-29
Lidocaine
Dosage: 5 ml, single
Indication: X-RAY
Start date: 2009-04-29
End date: 2009-04-29
Sodium Chloride
Dosage: 10 ml, single
Indication: Arthrogram
Start date: 2009-04-29
End date: 2009-04-29
Magnevist
Dosage: 1 ml, single
Indication: Arthrogram
Start date: 2009-04-29
End date: 2009-04-29
Possible Magnevist side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-12-20
Patient: female, weighing 108.0 kg (237.6 pounds)
Reactions: Ligament Injury, Procedural Pain, Incorrect Route of Drug Administration, Wrong Technique in Drug Usage Process, Septic Arthritis Staphylococcal, Fall, Off Label Use, Joint Swelling, Arthralgia, Gait Disturbance, Lymphoedema, Normochromic Normocytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sodium Chloride
Dosage: 10 ml, single
Indication: Arthrogram
Start date: 2009-04-29
End date: 2009-04-29
Magnevist
Dosage: 1 ml, single
Indication: Arthrogram
Start date: 2009-04-29
End date: 2009-04-29
Magnevist
Indication: Joint Injury
Lidocaine
Dosage: 5 ml, single
Indication: X-RAY
Start date: 2009-04-29
End date: 2009-04-29
Optiray 160
Dosage: 5-10 ml
Indication: X-RAY
Start date: 2009-04-29
End date: 2009-04-29
Other drugs received by patient: Soma; Naprosyn; Vicodin; Ambien; Buspirone HCL; Risperdal
Possible Magnevist side effects in male
Reported by a physician from United States on 2011-10-11
Patient: male
Reactions: Hypersensitivity, Abasia, Chills, Neuropathic Arthropathy, Osteomyelitis, Pyrexia, Erectile Dysfunction, Erythema, Off Label Use, Skin Ulcer, Oedema Peripheral, Ingrowing Nail, Coagulation Time Prolonged, Lethargy, Blister, Cellulitis, Pain in Extremity, Anaemia, Cystitis, Nephrogenic Systemic Fibrosis, Arthralgia, Heart Rate Increased, Insomnia, Leukocytosis, Blood Pressure Decreased, Asthenia, Disability
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Omniscan
Dosage: 20 ml, single
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-10-19
End date: 2006-10-19
Optimark
Dosage: 15 ml, single
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2007-04-12
End date: 2007-04-12
Magnevist
Dosage: 20 ml, single
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2007-07-25
End date: 2007-07-25
Omniscan
Other drugs received by patient: Lantus; Novolin / 00030501 /; Lasix; Coumadin; Novolog; Epogen
|
